期刊
WIENER KLINISCHE WOCHENSCHRIFT
卷 131, 期 1-2, 页码 29-44出版社
SPRINGER WIEN
DOI: 10.1007/s00508-019-1448-y
关键词
Autoimmune disease; Childbearing; Breastfeeding; Prescribing; TNF- inhibitors; DMARDs
资金
- Medical University of Vienna
An increasing and early-onset use of immunosuppressives and biologics has become more frequently seen among patients with inflammatory bowel diseases (IBD) and rheumatic disorders. Many women in their childbearing years currently receive such medications, and some of them in an interdisciplinary setting. Many questions arise in women already pregnant or wishing to conceive with respect to continuing or discontinuing treatment, the risks borne by the newborns and their mothers and long-term safety. Together with the Austrian Society of Rheumatology and Rehabilitation, the IBD working group of the Austrian Society of Gastroenterology and Hepatology has elaborated consensus statements on the use of immunosuppressives and biologics in pregnancy and lactation. This is the first Austrian interdisciplinary consensus on this topic. It is intended to serve as abasis and support for providing advice to our patients and their treating physicians.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据